Literature DB >> 7934147

Prevention of S-D-lactoylglutathione-induced inhibition of human leukaemia 60 cell growth by uridine.

L G Edwards1, P J Thornalley.   

Abstract

The anti-proliferative activity of S-D-lactoylglutathione is of interest since it has a low toxicity to differentiated and non-malignant proliferating tissues, and its mechanism of action appears to be dissimilar to other anti-proliferative agents. Addition of uridine completely and addition of cytidine partially prevented S-D-lactoylglutathione-induced growth inhibition of human leukaemia 60 (HL60) cells in vitro. Other nucleosides had no significant effect. The concentrations of UTP, CTP, UDP and also ATP, ADP, GTP and GDP decreased in S-D-lactoylglutathione-treated HL60 cells, whereas the concentration of UDP-N-acetylhexosamine (UDP-N-acetyl-glucosamine + N-acetyl-galactosamine) increased, prior to cell death. This suggests that the anti-proliferative effects of S-D-lactoylglutathione are mediated by inhibition of uridylate synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934147     DOI: 10.1016/0145-2126(94)90072-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Facile synthesis of (R)N-2-hydroxyacyl-L-cysteine derivatives: (R)N-2-hydroxyacyl transfer from enzymatically-synthesized (R)S-2-hydroxyacylglutathione derivatives to L-cysteine.

Authors:  A Adesida; L G Edwards; P J Thornalley
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

2.  Weak association of glyoxalase 1 (GLO1) variants with autism spectrum disorder.

Authors:  Jernej Kovač; Katarina Trebušak Podkrajšek; Marta Macedoni Lukšič; Tadej Battelino
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-03-27       Impact factor: 4.785

3.  Novel glyoxalase-I inhibitors possessing a "zinc-binding feature" as potential anticancer agents.

Authors:  Qosay A Al-Balas; Mohammad A Hassan; Nizar A Al-Shar'i; Nizar M Mhaidat; Ammar M Almaaytah; Fatima M Al-Mahasneh; Israa H Isawi
Journal:  Drug Des Devel Ther       Date:  2016-08-17       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.